Table 1 Baseline characteristics of the study population
n = 150 | |
|---|---|
Age [years] | 82 ± 4 |
Female sex % (n) | 52.3 (78) |
STS-score (%) | 6.4 ± 6.2 |
NYHA class III/ IV % (n) | 91.3 (137) |
COPD % (n) | 17.3 (26) |
Neurologic dysfunction % (n) | 13.3 (20) |
Chronic renal failure % (n) | 34.7 (52) |
Recent MI % (n) | 17.3 (26) |
Pulmonary hypertension % (n) | 48.7 (73) |
Stable CAD % (n) | 74 (111) |
Previous PCI % (n) | 47.3 (71) |
Previous CABG % (n) | 8.7 (13) |
Peripheral artery disease % (n) | 22 (33) |
Pacemaker % (n) | 13.4 (20) |
Atrial fibrillation % (n) | 45.3 (68) |
LVEF in normal range > 52% %(n) | 63.3 (95) |
Decreased LVEF ≤ 52% %(n) | 39.7 (55) |
Normal GLS ≤ − 19.7% (n) | 17.3 (26) |
Decreased GLS > − 19.7% (n) | 82.6 (124) |
Baseline LVEDP (mmHg) | 20.1 ± 8.6 |
Arterial hypertension % (n) | 85.3 (128) |
Diabetes mellitus % (n) | 31.3 (47) |
Adiposity % (n) | 28.2 (42) |